Alanna M. Windsor

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/3a9dff40-24ce-11ee-88ab-4d123afddc94.jpg

First Name

Alanna

Last Name

Windsor

NPI

1376980961

Faculty ID

16897

CMO Specialties

Clinical Terms

Employment Status

Voluntary

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

141714

Is Open Scheduling

On

Scott J. Schafler

https://assets.montefioreeinstein.org/profiles/images/Scott-Schafler.jpg

First Name

Scott

Last Name

Schafler

NPI

1417219585

Faculty ID

16440

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

55639

Is Open Scheduling

Off

Michel Nassar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/e21f1a40-bb36-11ec-bd24-2927171ec855.jpg

First Name

Michel

Last Name

Nassar

NPI

1851646558

Faculty ID

14086

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA).<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR).<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

5768

Biography

<p>Michel Nassar, MD, MSc, is Director, AeroDigestive Program at Children&rsquo;s Hospital at Montefiore, and Co-Director, CranioFacial Clinic and Associate Professor of Otolaryngology at Montefiore-Einstein. Dr. Nassar takes a multidisciplinary approach to patients with complex aerodigestive disease. His clinical interests include minimally invasive airway surgery and reconstruction, and the medical and surgical management of pediatric hearing loss, including endoscopic ear surgery, cochlear implants and bone anchored hearing aids (BAHA). He also has expertise in the medical and surgical management of velopharyngeal disorders.</p><p>Dr. Nassar earned his medical degree at Saint Joseph University in Beirut, Lebanon in 2005. He began his postgraduate training in France, completing an otolaryngology residency at Hotel Dieu de France Hospital in 2010 and his Masters in Surgical Sciences and pediatric otolaryngology fellowship in 2012. He then came to the United States, completing a pediatric otolaryngology fellowship at Cincinnati Children&rsquo;s Hospital in 2013.</p><p>In addition to his interests in the use of simulation in medical education, Dr. Nassar also has an interest in congenital cytomegalovirus (CMV) and hearing loss, including targeted CMV screening and the use of Valganciclovir for CMV-infected hearing-impaired infants (ValEAR). His work has been shared through peer-reviewed journals and oral presentations. He is also a reviewer for <em>Laryngoscope, the International Journal of Pediatric Otorhinolaryngology and the European Annals of Otorhinolaryngology</em>.</p><p>Dr. Nassar is a member of the American Academy of Otolaryngology&ndash;Head and Neck Surgery, the American Academy of Pediatrics and the International Federation of Oto-Rhino-Laryngological Societies. He has been listed among the <em>New York Times</em>&rsquo; Super Doctors - Rising Stars.</p>

Is Open Scheduling

On

Zocdoc Link

Howard S. Moskowitz

https://assets.montefioreeinstein.org/profiles/images/physphoto/Moskowitz_Howard_S_MD_PhD_11119836.jpg

First Name

Howard

Last Name

Moskowitz

NPI

1104082825

Faculty ID

14020

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Clinical focus is on the medical and surgical treatment of ear and skull base disorders in adults and children, including chronic ear disease, hearing loss, dizziness, cochlear implants and ear and skull base tumors.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Moskowitz&rsquo;s research focuses on the development of novel treatments for skull base disorders, management of vestibular disorders, quality improvement in medical education and understanding the neural bases of auditory processing.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

5756

Biography

<p>Howard S. Moskowitz, MD, PhD, is an attending physician and Associate Professor in the Department of Otorhinolaryngology&ndash;Head &amp; Neck Surgery at Montefiore-Einstein. His clinical focus is on the medical and surgical treatment of ear and skull base disorders in adults and children, which includes chronic ear disease, hearing loss, dizziness, cochlear implants and tumors of the ear and skull base.</p><p>A graduate of Cornell University, Dr. Moskowitz received his Bachelor of Science in 1998. In 2005, he earned his Doctor of Philosophy at Weill Graduate School of Medical Sciences, followed by his Doctor of Medicine in 2006 at Weill Medical College. He began his postdoctoral training at the University of Pittsburgh Medical Center, completing his residency in otolaryngology&ndash;head &amp; neck surgery in 2011. He then pursued a fellowship in otology, neurotology, and skull base surgery at Johns Hopkins Medical Institution, completing it in 2013.</p><p>Dr. Moskowitz&rsquo;s research focuses on the development of novel treatments for skull base disorders, management of vestibular disorders, quality improvement in medical education and understanding the neural bases of auditory processing. His work has been published in numerous peer-reviewed journals, books and abstracts, as well as presented nationally.</p><p>He is board certified in otolaryngology&ndash;head &amp; neck surgery and neurotology. In 2017, Dr. Moskowitz received the Teacher of the Year Award from the Department of Otorhinolaryngology&ndash;Head &amp; Neck Surgery. He was named one of New York Super Doctors Rising Star Edition from 2015 to 2017. Dr. Moskowitz is board certified by the American Board of Otolaryngology and is a member of the American Academy of Otolaryngology&ndash;Head and Neck Surgery and the American Neurotology Society.</p>

Is Open Scheduling

Off

Haleh Moazen

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Haleh

Last Name

Moazen

NPI

1427147750

Faculty ID

3862

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3980

Is Open Scheduling

Off

Elissa B. Gross

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/85291c10-3caf-11ec-80f7-67047826a941.jpg

First Name

Elissa

Last Name

Gross

NPI

1376618983

Faculty ID

15356

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

8972

Is Open Scheduling

Off

Marc J. Gibber

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/074d4710-269d-11ee-9689-cb15fe2b95df.jpg

First Name

Marc

Last Name

Gibber

NPI

1063677599

Faculty ID

14032

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Clinical focus is on diagnosing and treating nasal and sinus conditions, breathing disorders, ear conditions, swallowing or throat conditions, tonsillitis and general ear, nose and throat conditions.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Gibber&rsquo;s research focuses on innovation in healthcare, specifically digital health and remote patient monitoring.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

4706

Biography

<p>Marc Gibber, MD, is Director, General/Comprehensive Otolaryngology and Associate Professor at Montefiore-Einstein. His clinical focus is on the diagnosis and treatment of nasal and sinus conditions, breathing disorders, ear conditions, swallowing or throat conditions, tonsillitis and general ear, nose and throat conditions.</p><p>After receiving his Bachelor of Arts at Yeshiva University in 2002, Dr. Gibber came to Einstein for his medical education, earning his Doctor of Medicine in 2008. He continued at Einstein for this postdoctoral training, completing his residency in otorhinolaryngology&ndash;head and neck surgery in 2013.</p><p>Dr. Gibber&rsquo;s research focuses on innovation in healthcare, specifically digital health and remote patient monitoring. He also has an interest in surgical simulation and surgical education. He has shared his work through peer-reviewed journals, book chapters, poster presentations and invited lectures.</p><p>Dr. Gibber is board certified and is a member of the American Academy of Otolaryngology&ndash;Head and Neck Surgery and the Society for Simulation in Healthcare. He has been listed among the <em>New York Times</em>&rsquo; Super Doctors - Rising Stars.</p>

Is Open Scheduling

On

Mona Gangar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a6a37e20-24e4-11ee-88ab-4d123afddc94.jpg

First Name

Mona

Last Name

Gangar

NPI

1679700629

Faculty ID

13581

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Clinical interests are in all aspects of pediatric otorhinolaryngology with a focus on pediatric head and neck pathology, and special interests in pediatric thyroid disease, vascular anomalies, resident/medical student education and global health.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Gangar&rsquo;s research focuses on all aspects of pediatric otorhinolaryngology.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

4801

Biography

<p>Mona Gangar, MD, MS, is Director. Medical Students; Co-director, Pediatric thyroid program; Faculty Advisor, ENT interest group and Assistant Professor of Otorhinolaryngology&ndash;Head &amp; Neck Surgery at Montefiore-Einstein. Her clinical interests are in all aspects of pediatric otorhinolaryngology with a focus on pediatric head and neck pathology, and special interests in pediatric thyroid disease, vascular anomalies, resident/medical student education and global health.</p><p>In 1999, Dr. Gangar received her Bachelor of Science in neuroscience from the University of California Los Angeles. She attended MCP Hahnemann University from 2000 to 2002, earning her Master of Science in medical science. She then attended New York Medical College to pursue her Doctor of Medicine degree, earning it in 2006. Her postdoctoral training included an otorhinolaryngology&ndash;head and neck surgery residency at Einstein from 2006 to 2011, followed by a yearlong fellowship in pediatric otolaryngology at Rady&rsquo;s Children&rsquo;s Hospital, which she completed in 2012.</p><p>Dr. Gangar&rsquo;s research focuses on all aspects of pediatric otorhinolaryngology. She has shared her work through publication in journals and podium and poster presentations.</p><p>Dr. Gangar is board certified and is a member of the American Academy of Otolaryngology&ndash;Head and Neck Surgery and the American Society of Pediatric Otolaryngology.</p>

Is Open Scheduling

Off

Elizabeth A. Dinces

https://assets.montefioreeinstein.org/profiles/images/physphoto/Dinces_Elizabeth_MD_420x504.jpg

First Name

Elizabeth

Last Name

Dinces

NPI

1295806677

Faculty ID

1804

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Skull base tumors, M&eacute;ni&egrave;res disease and syndrome, cholesteatoma, ear and Mastoid infections, hearing and Inner ear disorders, hearing restoration procedures, cochlear implantation, facial nerve disorders, temporal bone trauma

Research Focus

Dr. Dinces&rsquo; basic science research focuses on understanding how the brain processes sounds into meaningful language and includes auditory scene analysis in the elderly, sound intensity processing in children and development of auditory processing after co

Elsevier Profile

EMR ID

4206

Biography

Upon earning her medical degree at Albert Einstein College of Medicine, Dr. Dinces completed her residency in otorhinolaryngology head and neck surgery at the University of Medicine and Dentistry of New Jersey and the Newark Eye and Ear Infirmary and her fellowship in neurotology/skullbase surgery at Northwestern University. She is Chairman of the Quality Improvement Committee at Montefiore Medical Center and Albert Einstein College of Medicine.

Is Open Scheduling

Off

James C.M. Brust

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/d035eaf0-5e6f-11ef-870a-2d4e33c2095c.jpg

First Name

James

Last Name

Brust

NPI

1508998485

Faculty ID

11307

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Brust is a Professor of Medicine, with joint appointments in the Divisions of General Internal Medicine and Infectious Diseases. He graduated from the College of Physicians &amp; Surgeons at Columbia University and completed both a residency in Internal Medicine and a fellowship in Infectious Diseases at the Columbia University Medical Center.&nbsp;</p>
<p>Dr. Brust's research is focused on the dual epidemics of multidrug-resistant tuberculosis (MDR TB) and HIV in South Africa. With multiple US and international collaborators, his multidisciplinary research group is studying treatment outcomes of MDR TB/HIV co-infected patients, transmission patterns of drug-resistant TB, pharmacology of new and repurposed TB medications, and genetic mechanisms of drug-resistance. He has funding from NIAID to examinine the emergence of resistance to the new TB medication bedaquiline in patients with MDR and XDR TB.&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p><strong><strong>Selected Publications</strong></strong></p>
<p><strong><strong>&nbsp;</strong></strong></p>
<p><strong><strong>Brust JCM</strong></strong>, Gandhi NR, Carrara H, Osburn G and Padayatchi N.&nbsp;<em>High Treatment Failure and Default Rates for Patients with MDR TB in KwaZulu-Natal, South Africa, 2000-2003.&nbsp;</em>Int J Tuberc Lung Dis. 2010;14(4):413-9</p>
<p><strong>&nbsp;</strong></p>
<p><strong>Brust JCM</strong>, Shah NS, Scott M, Chaiyachati K, Lygizos M, van der Merwe TL, Bamber S, Radebe Z, Loveday M, Moll AP, Margot B, Lalloo UG, Friedland GH, Gandhi NR. <em>Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care</em>. Int J Tuberc Lung Dis&nbsp;2012; 16:998-1004.</p>
<p><strong>&nbsp;</strong></p>
<p><strong>Brust JCM</strong>, Shah NS, van der Merwe TL, Bamber S, Ning Y, Heo M, Moll AP, Loveday M, Lalloo UG, Friedland GH, Gandhi NR. <em>Adverse events in an integrated, home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa.</em> J Acquir Immune Defic Syndr 2013; 62:436-440.</p>
<p><strong>&nbsp;</strong></p>
<p><strong>Brust JCM</strong>, Berman AR, Zalta B, Haramati LB, Ning Y, Heo H, van der Merwe TL, Bamber S, Moll AP, Friedland GH, Shah NS, Gandhi NR.<em>Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa<strong>.</strong></em>PLoS One 2013; 8(9): e73975. doi:10.1371/journal.pone.0073975</p>
<p>&nbsp;</p>
<p>Gandhi NR, <strong>Brust JCM</strong>, Moodley P, Weissman D, Heo M, Ning Y, Moll AP, Friedland GH, Sturm W, Shah NS. <em>Low M. tuberculosis strain diversity among multidrug- and extensively drug-resistant tuberculosis isolates from Tugela Ferry, South Africa, 2005-2006</em>. Emerg Infect Dis 2014; 20(3):394-401.</p>
<p>&nbsp;</p>
<p>Loveday M, Wallengren K, <strong>Brust J</strong>, Roberts J, Voce A, Margot B, Ngozo J, Master I, Cassell G, Padayatchi N. <em>Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.</em> Int J Tuberc Lung Dis. 2015 Feb;19(2):163-71.</p>
<p>&nbsp;</p>
<p>Niehaus AJ, Gandhi NR, Mathema B, Mlisana K, <strong>Brust JCM</strong>. High prevalence of inhA promoter mutations among patients with drug-resistant tuberculosis in KwaZulu-Natal, South Africa. PLoS One 2015; 10(9):e0135003. doi: 10.1371/journal.pone.0135003</p>
<p>&nbsp;</p>
<p>Shah NS, Auld S, <strong>Brust JCM</strong>, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T, Morris N, Mpangase P, Vally Omar S, Brown T, Narenchania A, Shaskina E, Kapwata T, Kreiswirth B, Gandhi NR. <em>Transmission of Extensively Drug-Resistant Tuberculosis in South Africa</em>. N Engl J Med 2017; 376(3):243-253</p>
<p>&nbsp;</p>
<p><strong>Brust JCM</strong>, Shah NS, Mlisana K, Moodley P, Allana S, Campbell A, Johnson BA, Master I, Mthiyane T, Lachman S, Larkan L-M, Ning Y, Malik A, Smith JP, Gandhi NR. <em>Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.</em> Clin Infect Dis. 2018; 66(8):1246-1253.</p>
<p>&nbsp;</p>
<p>Wasserman S, Denti P, <strong>Brust JCM</strong>, Abdelwahab M, Hlungulu S, Wiesner L, Norman J, Sirgel FA, Warren RM, Esmail A, Dheda K, Gandhi NR, Meintjes G, Maartens G. <em>Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection.</em> Antimicrob Agents Chemother 2019 63(3):e02164-18</p>
<p>&nbsp;</p>
<p>Meintjes G, <strong>Brust JCM</strong>, Nutall J, Maartens G. <em>Management of active tuberculosis in adults with HIV</em>. Lancet HIV 2019; 6: e463&ndash;74</p>
<p>&nbsp;</p>
<p>Smith JP, Gandhi NR, Shah NS, Mlisana K, Moodley P, Johnson BA, Allana S, Campbell A, Nelson KN, Master I, <strong>Brust JCM</strong>. <em>The impact of concurrent antiretroviral therapy and MDR-TB treatment on adverse events</em>. J Acquir Immune Defic Syndr 2020; 83(1):47-55</p>
<p>&nbsp;</p>
<p>Ngwalero P*, <strong>Brust JCM*</strong>, van Beek SW, Wasserman S, Maartens G, Meintjes G, Joubert A, Norman J, Castel S, Gandhi NR, Denti P, McIlleron H, Svensson EM, Wiesner L. Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB. Antmicrob Agents Chemother. 2021; 65(11):e0239920. doi: 10.1128/AAC.02399-20</p>
<p class="MsoListParagraph" style="mso-add-space: auto; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list 40.5pt; margin: 0in 0in 6.0pt 40.5pt;">&nbsp;</p>
<p><strong style="text-indent: -0.25in;">Brust JCM</strong><span style="text-indent: -0.25in;">, Gandhi NR, Wasserman S, Maartens G, Omar SV, Ismail NA, Campbell A, Joseph L, Hahn A, Allana S, Hernandez-Romieu AC, Zhang C, Mlisana K, Viljoen CA, Zalta B, Ebrahim I, Franczek M, Master I, Ramangoaela L, Te Riele J, Meintjes G; PROBeX Study Team. </span><em style="text-indent: -0.25in;">Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study. </em><span style="text-indent: -0.25in;">Clin Infect Dis. 2021; 73(11):2083-2092</span></p>
<p>&nbsp;</p>

EMR ID

5132

Is Open Scheduling

Off